ALDX
Aldeyra The
NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY
$0.68
+6.61% today
Updated 2026-10-28
Market cap
$42.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$1 – $6
Volume
1.2M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.5
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-9.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$6.60
+865.48%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -9.18 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-4.61M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-62.02M | $-37.54M | $-55.85M | $-33.85M | $-5.45M |
| EPS | — | — | — | — | $-0.38 |
| Free cash flow | $-56.65M | $-30.33M | $-43.21M | $-33.35M | $-4.61M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Aldeyra The trades at $0.68. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -9.18, it sits in the distress.
Frequently asked questions
What is Aldeyra The's stock price?
Aldeyra The (ALDX) trades at $0.68.
Is Aldeyra The overvalued?
Aldeyra The carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Aldeyra The (ALDX)?
The 12-month analyst consensus target is $6.60, about 865.5% above the current $0.68. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Aldeyra The's Altman Z-Score is -9.18, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE—
Beta1.20
50D MA$1.32
200D MA$2.46
Shares out0.06B
Float0.05B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—